Matches in Nanopublications for { ?s ?p "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP344052.RAQxrhTZhHBMGZmyFl_r0Wz0smeI42RV6IUrPb8nsMiJA130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344052.RAQxrhTZhHBMGZmyFl_r0Wz0smeI42RV6IUrPb8nsMiJA130_provenance.
- NP55638.RApWUuVOX-7Z30RmX8UTWFlKz31h8myDtQL3Q6Zs7_F4U130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55638.RApWUuVOX-7Z30RmX8UTWFlKz31h8myDtQL3Q6Zs7_F4U130_provenance.
- NP55758.RAijuMeqxBIUjn2smIWNXxKiHKj3ZMT8Dj8hhHTKiy0OI130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55758.RAijuMeqxBIUjn2smIWNXxKiHKj3ZMT8Dj8hhHTKiy0OI130_provenance.
- NP129011.RAAQb0R9goxmmN27EX7d11kJ8bMvZI3RdphpV4He5nNCQ130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129011.RAAQb0R9goxmmN27EX7d11kJ8bMvZI3RdphpV4He5nNCQ130_provenance.
- NP344576.RAulCobubCqQMDzpFVrsWb6wTAxfq3xUDe3EwC-Azi29Q130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344576.RAulCobubCqQMDzpFVrsWb6wTAxfq3xUDe3EwC-Azi29Q130_provenance.
- NP129014.RAvKnJlnxYeBE8NecszhyGcasd0xwHLLA6-l_t9hN_ywM130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129014.RAvKnJlnxYeBE8NecszhyGcasd0xwHLLA6-l_t9hN_ywM130_provenance.
- NP689472.RAvVfcakvYPMoR_PLm-rWmgmT2Sk_min36MtzCm4vm8K0130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689472.RAvVfcakvYPMoR_PLm-rWmgmT2Sk_min36MtzCm4vm8K0130_provenance.
- NP689475.RA70l2hnTo7uxczNipy5_Y8UhLByBl0qt9t95gc5d71Hc130_assertion description "[CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689475.RA70l2hnTo7uxczNipy5_Y8UhLByBl0qt9t95gc5d71Hc130_provenance.